DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Radretumab
Radretumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
(12) United States Patent (10) Patent No.: US 9,161,992 B2 Jefferies Et Al
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
The Two Tontti Tudiul Lui Hi Ha Unit
NSCLC Therapeutics in Asia-Pacific Markets to 2019 Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
INN Working Document 05.179 Update 2011
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Radiochemistry, Production Processes, Labeling Methods, and Immunopet Imaging Pharmaceuticals of Iodine-124
(INN) for Biological and Biotechnological Substances
Targeted Radionuclide Therapy of Human Tumors
Ep 2739649 B1
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
A Novel Format for Recombinant Antibody-Interleukin-2 Fusion Proteins Exhibits Superior Tumor-Targeting Properties in Vivo
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
The Advancement of Immuno-PET Into Clinical Use Brian D
Top View
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
WO 2016/126552 Al 11 August 2016 (11.08.2016) P O P C T
Mai Muita in Acut Ca Uti on Muunni
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
Targeted Radionuclide Therapy of Early Brain Metastases Nadia Falzone1*, Nicole L
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Listes De DCI Proposées N'implique Aucune Recommandation En Vue De L'utilisation De La Substance Correspondante En Médecine Ou En Pharmacie
Us 2019 / 0202839 A1
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2013/119960 A2 15 August 2013 (15.08.2013) P O P C T
(INN) for Biological and Biotechnological Substances
Potential Drugs Used in the Antibody–Drug Conjugate (ADC) Architecture for Cancer Therapy
Le Cuivre-64
Ep 3088005 A1
Antibody-Cytokine Fusion Proteins: Biopharmaceuticals with Immunomodulatory Properties for Cancer Therapy
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Radretumab Radioimmunotherapy in Patients with Brain Metastasis: a 124I-L19SIP Dosimetric PET Study
(12) 按照专利合作条约所公布的国际申请w O 2016/050208
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al
Human BMPR1B Amino Acid Sequence